{"ticker": {"uuid": "946c0724-0a2a-4f36-ba3b-2515d7faf66b", "symbol": "PDEX", "name": "Pro-Dex Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Instruments & Supplies"}, "articles": [{"title": "Pro Dex director Domingo sells $47,145 of company stock By Investing.com", "summary": "Angelita Rebamontan Domingo, a director at PRO DEX INC (NASDAQ: PDEX), recently sold 998 shares of the company's common stock for $47,145. The transaction occurred on March 16, 2026, at $47.24 per share. Following the sale, Domingo directly holds 18,779 shares, and the stock has ", "url": "https://uk.investing.com/news/stock-market-news/pro-dex-director-domingo-sells-47145-of-company-stock-93CH-4770661", "source_name": "Investing.com UK", "published_at": "2026-07-14T21:44:55", "published_display": "14 Jul 2026 21:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pro-Dex director (NASDAQ: PDEX) sells 998 shares in open market trade", "summary": "A director at Pro-Dex Inc. (NASDAQ: PDEX), Domingo Angelita Rebamontan, sold 998 shares of common stock in an open-market transaction on March 16, 2026, at a price of $47.24 per share. Following this sale, the director directly holds 18,779 shares of Pro-Dex common stock. The tra", "url": "https://www.stocktitan.net/sec-filings/PDEX/form-4-pro-dex-inc-insider-trading-activity-60d8d839da2d.html", "source_name": "Stock Titan", "published_at": "2026-07-14T21:44:55", "published_display": "14 Jul 2026 21:44", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Pro-Dex Inc For: 14 July By Investing.com", "summary": "This article from Investing.com announces the filing of Form 4 for Pro-Dex Inc. on July 14. The concise piece indicates a financial disclosure but provides no further details on the content of the form. It notes the stock symbol PDEX is down 5.35%.", "url": "https://uk.investing.com/news/stock-market-news/form-4-prodex-inc-for-14-july-93CH-4770666", "source_name": "Investing.com UK", "published_at": "2026-07-14T21:44:55", "published_display": "14 Jul 2026 21:44", "sentiment": "negative", "sentiment_pct": 32, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pro-Dex Inc. (PDEX) Q2 2026 Earnings: EPS Soars 89.75% Above Estimates as Profitability Surprises - Low Growth Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxOMTNHVmljYVNlNl9tMUJjZ01rdjFwTzB3aFNMcGZ1XzJEcmNkaERsZUMzMzZ5Z3RSN2pxUVlhSXBoWllpZkxtN0NwelNiUWoxNW53TVl0YzRlNEpJWTR3M09lUm9zZkFpajNGVzVnMlNqMGNERkcxMXlzM2tPWlkzQTc3SThnbnBYVFRpV3RDZ21IVi13endjSVE0NTUzaVNXME9BS0pjUlMweURfVHNIcm9ockNXbkRWd01GNHNMSmF2Y2h3X3FCSmVBSFNUdE1COGk1eVRhLVpYblE?oc=5", "source_name": "B\u00f6l\u00fcm Sonu Canavar\u0131", "published_at": "2026-07-09T10:41:38+00:00", "published_display": "09 Jul 2026 10:41", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision Trading with Pro-dex Inc. (PDEX) Risk Zones", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxNNHFvNkFyZkZLcWZYU2xsS1M4LUpvWldsVjlFOHJRTmZvR1N2UzBiWDQ1Z1o1NXdyMFhKYVBQUzlUQzV2U0FwU05HNzF6YWhheWp2V0lWQ0VpbnJ2YjQ2ejVBVGx3c0hCcGpKRTJVcTNpcEdtNFhoQTlTUm52VXFMVWg5R3NaYXNDSjNRSEFjRjBoQ0F0UmtkdkZIUUxrTjJpVHRxTEVoR2xMZERiQzFMZnpDTXYzdW1qOFEyaG4yZmRjWlRFY0xWZzN5dw?oc=5", "source_name": "Stock Traders Daily", "published_at": "2026-07-09T07:56:02+00:00", "published_display": "09 Jul 2026 07:56", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pro-Dex Inc (PDEX) awards director 6,800 shares; 2,488 withheld for taxes", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOWG0zY3RraWxCWWFFbm5qZ0piaUpnZTNORXdSejlnSFJfYm04S0RHekd5X1RxLXBiRHIyQ0FTeTRjZWFQbGdrQTNQNDY1R1hybnZxQ1lpUV9MMXhaQ2xsMk80cllfdllUVEtVR1Bkb2ZKeldCaGZtOTZDRmlsS2tOX0pYZXp0Vi1TbERxQ2Y4RU9NVS05ek1OcC1KejYyRVFyVm9mS0Rra1Y?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T20:00:29+00:00", "published_display": "06 Jul 2026 20:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PDEX - Pro-Dex Inc Revenue Breakdown", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE02RE03cTAyR25ENGxsX1pQZVoySzFrU2FkM293MVoySmhfT1JPTWhNSE5IZjBOWFNSa05TNjVnMl96ZGJ6QnFqY1lQOEJXUUhUZFFaZUp6TF96UQ?oc=5", "source_name": "Finviz", "published_at": "2026-07-05T08:22:10+00:00", "published_display": "05 Jul 2026 08:22", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PDEX Price Today: Pro-Dex Inc New Stock Price, Quote & Chart | MEXC", "summary": "This article provides current stock information for Pro-Dex Inc New (PDEX), including its latest trading price of $62.03, recent performance, and key market data. It also details the company's business activities as a designer and manufacturer of powered surgical instruments and ", "url": "https://www.mexc.com/stocks/pdex", "source_name": "MEXC", "published_at": "2026-07-02T05:09:13", "published_display": "02 Jul 2026 05:09", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PDEX - Pro-Dex Inc Stock Price and Quote", "summary": "This article provides a comprehensive overview of Pro-Dex Inc. (PDEX) stock, including its current price, key financial metrics, performance indicators, and recent news headlines. It details the company's valuation ratios, growth rates, insider and institutional ownership, and li", "url": "https://finviz.com/stock?t=PDEX", "source_name": "Finviz", "published_at": "2026-06-02T16:40:26", "published_display": "02 Jun 2026 16:40", "sentiment": "positive", "sentiment_pct": 62, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pro-Dex Inc. (PDEX) Consolidates Near Support as Technicals Point to Range-Bound Trading - Last Point Support", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPY1VST2NvdkprVFpnSHBNTXBCSmRWSkJoaEhUVlRhbVNReVgyTkVYYS1meHNHTFE2VHZFODVMV2hmX3FDWGlzbVNuLVhzMDdNODZsczMxMlJBeDRLYnhQQmFXTHlvNzFEYXRLdGlET0tWbm9CUmp1WEVSTjUxMGduQUdVdldMU0RWUzhFVzBVd0xBMnFKSkdrWjEwbGtIU3czT3RwMUVMaFNrT0JhNy0zZUtHZlgycTZRRXlQdU5xVVZiM1BIWmlQbQ?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pro-Dex: Still A Buy, But Don\u2019t Chase (NASDAQ:PDEX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxOSzZHU1d6SU8zbXdiTUZsX2gxaDlIRFVZUHRqaFFlb0NKcmVDSGJBbV9LajFibWxGZzJ0Tm82ZTU3ZEFHWmtJOUEtWHFJNkhpUHJha3Q4UkFERmtYdGZheng5Mkc3MEM1S0tra1IzRG5DUGJuN3RiMGt0dlhKOEl5OWRwQTVPMUpoRmdR?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pro-Dex (NASDAQ: PDEX) Q3 revenue up 15% as EPS climbs to $1.20", "summary": "Pro-Dex, Inc. reported a 15% increase in Q3 2026 revenue to $19.9 million and a 16% increase for the nine months ended March 31, 2026, reaching $57.1 million. Diluted EPS rose to $1.20 for the quarter and $3.27 for the nine-month period, significantly boosted by realized gains fr", "url": "https://www.stocktitan.net/sec-filings/PDEX/8-k-pro-dex-inc-reports-material-event-8bc28e09c97e.html", "source_name": "Stock Titan", "published_at": "2026-05-03T16:39:24", "published_display": "03 May 2026 16:39", "sentiment": "positive", "sentiment_pct": 63, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 8-K - Current report", "summary": "Pro-Dex, Inc. (NASDAQ: PDEX) announced the completion of its acquisition of Advanced Precision Machining LLC (APM) on February 9, 2026. This acquisition, valued at approximately $8.65 million, is expected to enhance Pro-Dex's manufacturing capabilities for medical device and aero", "url": "https://br.advfn.com/noticias/EDGAR2/2026/artigo/97825792", "source_name": "ADVFN", "published_at": "2026-04-12T09:38:54", "published_display": "12 Apr 2026 09:38", "sentiment": "positive", "sentiment_pct": 72, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PDEX Should I Buy", "summary": "The article analyzes Pro-Dex Inc (PDEX) and concludes it is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The recommendation is based on strong financial performance, positive technical indicators, and consistent growth in revenue, n", "url": "https://intellectia.ai/en/stock/PDEX/should-i-buy", "source_name": "Intellectia AI", "published_at": "2026-03-30T15:40:27", "published_display": "30 Mar 2026 15:40", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AIRT,PDEX Volatility & Greeks", "summary": "This article provides detailed financial data and recent news for Air T Inc. (AIRT) and Pro-Dex Inc. (PDEX). Both sections include comprehensive stock performance metrics, insider ownership, key financial figures, and a chronological list of recent press releases and financial an", "url": "https://finviz.com/quote.ashx?t=AIRT%2CPDEX&ta=1&p=d&ty=ocv&r=m1&e=2026-03-14", "source_name": "Finviz - Stock Screener", "published_at": "2026-03-14T08:38:41", "published_display": "14 Mar 2026 08:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pro-Dex (NASDAQ:PDEX) Share Price Crosses Above 200 Day Moving Average - Time to Sell?", "summary": "Pro-Dex (NASDAQ:PDEX) recently saw its share price cross above its 200-day moving average, trading at $39.48. Despite this technical milestone, the stock remains below its 50-day moving average, indicating mixed short-term and long-term signals. Analysts currently rate PDEX as a ", "url": "https://www.marketbeat.com/instant-alerts/pro-dex-nasdaqpdex-share-price-crosses-above-200-day-moving-average-time-to-sell-2026-02-14/", "source_name": "MarketBeat", "published_at": "2026-02-14T09:27:26", "published_display": "14 Feb 2026 09:27", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pro-Dex (NASDAQ:PDEX) Stock Crosses Above 200-Day Moving Average - What's Next?", "summary": "Pro-Dex (NASDAQ:PDEX) stock recently crossed above its 200-day moving average, signaling a potential bullish trend. The medical instruments supplier reported strong Q4 results, surpassing earnings and revenue estimates, and maintains healthy profitability with low leverage. Analy", "url": "https://www.marketbeat.com/instant-alerts/pro-dex-nasdaqpdex-stock-crosses-above-200-day-moving-average-whats-next-2026-02-06/", "source_name": "MarketBeat", "published_at": "2026-02-07T09:27:32", "published_display": "07 Feb 2026 09:27", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pro-Dex (NASDAQ:PDEX) Stock Crosses Above 200 Day Moving Average - Should You Sell?", "summary": "Pro-Dex (NASDAQ:PDEX) recently saw its shares cross above their 200-day moving average. The company reported strong quarterly earnings, beating analyst estimates for both EPS and revenue, alongside healthy net margins and return on equity. Analysts currently rate the stock as a \"", "url": "https://www.marketbeat.com/instant-alerts/pro-dex-nasdaqpdex-stock-crosses-above-200-day-moving-average-should-you-sell-2026-02-06/", "source_name": "MarketBeat", "published_at": "2026-02-07T09:27:32", "published_display": "07 Feb 2026 09:27", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pro Dex (PDEX) One Off Gain Clouds 68% Trailing Earnings Growth Narrative", "summary": "Pro-Dex (PDEX) reported Q2 2026 revenue of US$18.7 million and Basic EPS of US$0.67, with trailing twelve-month revenue at US$72.1 million and Basic EPS at US$3.48. Despite 68% trailing earnings growth, these figures were significantly boosted by a US$4.7 million one-off gain, ra", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-pdex/pro-dex/news/pro-dex-pdex-one-off-gain-clouds-68-trailing-earnings-growth", "source_name": "Simply Wall St", "published_at": "2026-02-06T04:53:00", "published_display": "06 Feb 2026 04:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Midday Stock Roundup: Pro-Dex Rises 5.6%", "summary": "Pro-Dex Inc. saw its shares rise 5.6% to $41.30, with hedge funds owning a significant portion of the medical device maker. In contrast, Evolus Inc. experienced a 4.1% drop after two analyst firms lowered their price targets due to recent downgrades. The article also provides a r", "url": "https://www.ocbj.com/finance/stocks/midday-stock-roundup-pro-dex-rises-5-6/", "source_name": "Orange County Business Journal", "published_at": "2026-01-26T18:27:33", "published_display": "26 Jan 2026 18:27", "sentiment": "positive", "sentiment_pct": 74, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "With 37% ownership, Pro-Dex, Inc. (NASDAQ:PDEX) has piqued the interest of hedge funds investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE1HSjFSTjhPVlQtWUJIdXdIa1RjTmRYbW1QYkVSWlVJN1V0T0tOdnI4N2Zhd25SU2hRUzlZOTg4dzBOOHBSeUkzSVZPUjB2cF9aaHZrOE1rT0VRZ0FZN0tXZGdYcllvOWxKcFVvaC12NzdCR1dDc0tKSU13?oc=5", "source_name": "Market source", "published_at": "2026-01-25T08:00:00+00:00", "published_display": "25 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pro-Dex: A Niche Surgical Tools Microcap Trading At A Discount (NASDAQ:PDEX)", "summary": "Pro-Dex (PDEX) manufactures powered surgical instruments and industrial air motors, serving niche markets in orthopedics, CMF, and thoracic procedures. Despite currently having a high concentration of revenue from a single customer (78% of sales), the company is considered underv", "url": "https://seekingalpha.com/article/4860659-pro-dex-a-niche-surgical-tools-microcap-trading-at-a-discount", "source_name": "Seeking Alpha", "published_at": "2026-01-18T00:57:42", "published_display": "18 Jan 2026 00:57", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Think Pro-Dex (NASDAQ:PDEX) Can Manage Its Debt With Ease", "summary": "Pro-Dex, Inc. (NASDAQ:PDEX) appears to manage its debt effectively, holding US$13.2m in debt against US$10.6m in cash, resulting in a net debt of US$2.69m. The company's strong balance sheet is further supported by US$6.11m more liquid assets than total liabilities. While its con", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-pdex/pro-dex/news/we-think-pro-dex-nasdaqpdex-can-manage-its-debt-with-ease", "source_name": "Simply Wall Street", "published_at": "2026-01-14T08:27:43", "published_display": "14 Jan 2026 08:27", "sentiment": "positive", "sentiment_pct": 70, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "D.A. Davidson & CO. Increases Holdings in Pro-Dex, Inc. $PDEX", "summary": "D.A. Davidson & CO. significantly increased its stake in Pro-Dex, Inc. (NASDAQ:PDEX) by 152.3% in the third quarter, now owning 26,073 shares worth $883,000. Other institutional investors also adjusted their holdings in the medical instruments supplier. Analysts have a \"Moderate ", "url": "https://www.defenseworld.net/2026/01/12/d-a-davidson-co-increases-holdings-in-pro-dex-inc-pdex.html", "source_name": "Defense World", "published_at": "2026-01-12T09:27:08", "published_display": "12 Jan 2026 09:27", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pro-Dex Valuation Is Attractive Despite Customer Risk (NASDAQ:PDEX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPMk1BazNrSWlUbjRqTExZM2JHMmMzczNwUTk5cHlRZHBGSlVzY184bXFEbW9IV205QTVmZEdORS1WMXp0R3FVVzBSX1hmck5GQ1pHNU1rT1RZNmFicjZMdk9TVXdaNTVjNkhDYTlvUHlTZHpOVm5VejFael9ocTI2R0FzSzEtTk8zLXZCT2ZkS1YyTXY2eHlpcWRB?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-01-08T08:00:00+00:00", "published_display": "08 Jan 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Pro Dex director Domingo sells $47,145 of company stock By Investing.com", "summary": "Angelita Rebamontan Domingo, a director at PRO DEX INC (NASDAQ: PDEX), recently sold 998 shares of the company's common stock for $47,145. The transaction occurred on March 16, 2026, at $47.24 per share. Following the sale, Domingo directly holds 18,779 shares, and the stock has ", "url": "https://uk.investing.com/news/stock-market-news/pro-dex-director-domingo-sells-47145-of-company-stock-93CH-4770661", "source_name": "Investing.com UK", "published_at": "2026-07-14T21:44:55", "published_display": "14 Jul 2026 21:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pro-Dex director (NASDAQ: PDEX) sells 998 shares in open market trade", "summary": "A director at Pro-Dex Inc. (NASDAQ: PDEX), Domingo Angelita Rebamontan, sold 998 shares of common stock in an open-market transaction on March 16, 2026, at a price of $47.24 per share. Following this sale, the director directly holds 18,779 shares of Pro-Dex common stock. The tra", "url": "https://www.stocktitan.net/sec-filings/PDEX/form-4-pro-dex-inc-insider-trading-activity-60d8d839da2d.html", "source_name": "Stock Titan", "published_at": "2026-07-14T21:44:55", "published_display": "14 Jul 2026 21:44", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Pro-Dex Inc For: 14 July By Investing.com", "summary": "This article from Investing.com announces the filing of Form 4 for Pro-Dex Inc. on July 14. The concise piece indicates a financial disclosure but provides no further details on the content of the form. It notes the stock symbol PDEX is down 5.35%.", "url": "https://uk.investing.com/news/stock-market-news/form-4-prodex-inc-for-14-july-93CH-4770666", "source_name": "Investing.com UK", "published_at": "2026-07-14T21:44:55", "published_display": "14 Jul 2026 21:44", "sentiment": "negative", "sentiment_pct": 32, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pro-Dex Inc. (PDEX) Q2 2026 Earnings: EPS Soars 89.75% Above Estimates as Profitability Surprises - Low Growth Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxOMTNHVmljYVNlNl9tMUJjZ01rdjFwTzB3aFNMcGZ1XzJEcmNkaERsZUMzMzZ5Z3RSN2pxUVlhSXBoWllpZkxtN0NwelNiUWoxNW53TVl0YzRlNEpJWTR3M09lUm9zZkFpajNGVzVnMlNqMGNERkcxMXlzM2tPWlkzQTc3SThnbnBYVFRpV3RDZ21IVi13endjSVE0NTUzaVNXME9BS0pjUlMweURfVHNIcm9ockNXbkRWd01GNHNMSmF2Y2h3X3FCSmVBSFNUdE1COGk1eVRhLVpYblE?oc=5", "source_name": "B\u00f6l\u00fcm Sonu Canavar\u0131", "published_at": "2026-07-09T10:41:38+00:00", "published_display": "09 Jul 2026 10:41", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision Trading with Pro-dex Inc. (PDEX) Risk Zones", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxNNHFvNkFyZkZLcWZYU2xsS1M4LUpvWldsVjlFOHJRTmZvR1N2UzBiWDQ1Z1o1NXdyMFhKYVBQUzlUQzV2U0FwU05HNzF6YWhheWp2V0lWQ0VpbnJ2YjQ2ejVBVGx3c0hCcGpKRTJVcTNpcEdtNFhoQTlTUm52VXFMVWg5R3NaYXNDSjNRSEFjRjBoQ0F0UmtkdkZIUUxrTjJpVHRxTEVoR2xMZERiQzFMZnpDTXYzdW1qOFEyaG4yZmRjWlRFY0xWZzN5dw?oc=5", "source_name": "Stock Traders Daily", "published_at": "2026-07-09T07:56:02+00:00", "published_display": "09 Jul 2026 07:56", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pro-Dex Inc (PDEX) awards director 6,800 shares; 2,488 withheld for taxes", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOWG0zY3RraWxCWWFFbm5qZ0piaUpnZTNORXdSejlnSFJfYm04S0RHekd5X1RxLXBiRHIyQ0FTeTRjZWFQbGdrQTNQNDY1R1hybnZxQ1lpUV9MMXhaQ2xsMk80cllfdllUVEtVR1Bkb2ZKeldCaGZtOTZDRmlsS2tOX0pYZXp0Vi1TbERxQ2Y4RU9NVS05ek1OcC1KejYyRVFyVm9mS0Rra1Y?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T20:00:29+00:00", "published_display": "06 Jul 2026 20:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PDEX - Pro-Dex Inc Revenue Breakdown", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE02RE03cTAyR25ENGxsX1pQZVoySzFrU2FkM293MVoySmhfT1JPTWhNSE5IZjBOWFNSa05TNjVnMl96ZGJ6QnFqY1lQOEJXUUhUZFFaZUp6TF96UQ?oc=5", "source_name": "Finviz", "published_at": "2026-07-05T08:22:10+00:00", "published_display": "05 Jul 2026 08:22", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PDEX Price Today: Pro-Dex Inc New Stock Price, Quote & Chart | MEXC", "summary": "This article provides current stock information for Pro-Dex Inc New (PDEX), including its latest trading price of $62.03, recent performance, and key market data. It also details the company's business activities as a designer and manufacturer of powered surgical instruments and ", "url": "https://www.mexc.com/stocks/pdex", "source_name": "MEXC", "published_at": "2026-07-02T05:09:13", "published_display": "02 Jul 2026 05:09", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PDEX - Pro-Dex Inc Stock Price and Quote", "summary": "This article provides a comprehensive overview of Pro-Dex Inc. (PDEX) stock, including its current price, key financial metrics, performance indicators, and recent news headlines. It details the company's valuation ratios, growth rates, insider and institutional ownership, and li", "url": "https://finviz.com/stock?t=PDEX", "source_name": "Finviz", "published_at": "2026-06-02T16:40:26", "published_display": "02 Jun 2026 16:40", "sentiment": "positive", "sentiment_pct": 62, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pro-Dex Inc. (PDEX) Consolidates Near Support as Technicals Point to Range-Bound Trading - Last Point Support", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPY1VST2NvdkprVFpnSHBNTXBCSmRWSkJoaEhUVlRhbVNReVgyTkVYYS1meHNHTFE2VHZFODVMV2hmX3FDWGlzbVNuLVhzMDdNODZsczMxMlJBeDRLYnhQQmFXTHlvNzFEYXRLdGlET0tWbm9CUmp1WEVSTjUxMGduQUdVdldMU0RWUzhFVzBVd0xBMnFKSkdrWjEwbGtIU3czT3RwMUVMaFNrT0JhNy0zZUtHZlgycTZRRXlQdU5xVVZiM1BIWmlQbQ?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pro-Dex: Still A Buy, But Don\u2019t Chase (NASDAQ:PDEX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxOSzZHU1d6SU8zbXdiTUZsX2gxaDlIRFVZUHRqaFFlb0NKcmVDSGJBbV9LajFibWxGZzJ0Tm82ZTU3ZEFHWmtJOUEtWHFJNkhpUHJha3Q4UkFERmtYdGZheng5Mkc3MEM1S0tra1IzRG5DUGJuN3RiMGt0dlhKOEl5OWRwQTVPMUpoRmdR?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pro-Dex (NASDAQ: PDEX) Q3 revenue up 15% as EPS climbs to $1.20", "summary": "Pro-Dex, Inc. reported a 15% increase in Q3 2026 revenue to $19.9 million and a 16% increase for the nine months ended March 31, 2026, reaching $57.1 million. Diluted EPS rose to $1.20 for the quarter and $3.27 for the nine-month period, significantly boosted by realized gains fr", "url": "https://www.stocktitan.net/sec-filings/PDEX/8-k-pro-dex-inc-reports-material-event-8bc28e09c97e.html", "source_name": "Stock Titan", "published_at": "2026-05-03T16:39:24", "published_display": "03 May 2026 16:39", "sentiment": "positive", "sentiment_pct": 63, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 8-K - Current report", "summary": "Pro-Dex, Inc. (NASDAQ: PDEX) announced the completion of its acquisition of Advanced Precision Machining LLC (APM) on February 9, 2026. This acquisition, valued at approximately $8.65 million, is expected to enhance Pro-Dex's manufacturing capabilities for medical device and aero", "url": "https://br.advfn.com/noticias/EDGAR2/2026/artigo/97825792", "source_name": "ADVFN", "published_at": "2026-04-12T09:38:54", "published_display": "12 Apr 2026 09:38", "sentiment": "positive", "sentiment_pct": 72, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PDEX Should I Buy", "summary": "The article analyzes Pro-Dex Inc (PDEX) and concludes it is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The recommendation is based on strong financial performance, positive technical indicators, and consistent growth in revenue, n", "url": "https://intellectia.ai/en/stock/PDEX/should-i-buy", "source_name": "Intellectia AI", "published_at": "2026-03-30T15:40:27", "published_display": "30 Mar 2026 15:40", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AIRT,PDEX Volatility & Greeks", "summary": "This article provides detailed financial data and recent news for Air T Inc. (AIRT) and Pro-Dex Inc. (PDEX). Both sections include comprehensive stock performance metrics, insider ownership, key financial figures, and a chronological list of recent press releases and financial an", "url": "https://finviz.com/quote.ashx?t=AIRT%2CPDEX&ta=1&p=d&ty=ocv&r=m1&e=2026-03-14", "source_name": "Finviz - Stock Screener", "published_at": "2026-03-14T08:38:41", "published_display": "14 Mar 2026 08:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pro-Dex (NASDAQ:PDEX) Share Price Crosses Above 200 Day Moving Average - Time to Sell?", "summary": "Pro-Dex (NASDAQ:PDEX) recently saw its share price cross above its 200-day moving average, trading at $39.48. Despite this technical milestone, the stock remains below its 50-day moving average, indicating mixed short-term and long-term signals. Analysts currently rate PDEX as a ", "url": "https://www.marketbeat.com/instant-alerts/pro-dex-nasdaqpdex-share-price-crosses-above-200-day-moving-average-time-to-sell-2026-02-14/", "source_name": "MarketBeat", "published_at": "2026-02-14T09:27:26", "published_display": "14 Feb 2026 09:27", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pro-Dex (NASDAQ:PDEX) Stock Crosses Above 200-Day Moving Average - What's Next?", "summary": "Pro-Dex (NASDAQ:PDEX) stock recently crossed above its 200-day moving average, signaling a potential bullish trend. The medical instruments supplier reported strong Q4 results, surpassing earnings and revenue estimates, and maintains healthy profitability with low leverage. Analy", "url": "https://www.marketbeat.com/instant-alerts/pro-dex-nasdaqpdex-stock-crosses-above-200-day-moving-average-whats-next-2026-02-06/", "source_name": "MarketBeat", "published_at": "2026-02-07T09:27:32", "published_display": "07 Feb 2026 09:27", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pro-Dex (NASDAQ:PDEX) Stock Crosses Above 200 Day Moving Average - Should You Sell?", "summary": "Pro-Dex (NASDAQ:PDEX) recently saw its shares cross above their 200-day moving average. The company reported strong quarterly earnings, beating analyst estimates for both EPS and revenue, alongside healthy net margins and return on equity. Analysts currently rate the stock as a \"", "url": "https://www.marketbeat.com/instant-alerts/pro-dex-nasdaqpdex-stock-crosses-above-200-day-moving-average-should-you-sell-2026-02-06/", "source_name": "MarketBeat", "published_at": "2026-02-07T09:27:32", "published_display": "07 Feb 2026 09:27", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pro Dex (PDEX) One Off Gain Clouds 68% Trailing Earnings Growth Narrative", "summary": "Pro-Dex (PDEX) reported Q2 2026 revenue of US$18.7 million and Basic EPS of US$0.67, with trailing twelve-month revenue at US$72.1 million and Basic EPS at US$3.48. Despite 68% trailing earnings growth, these figures were significantly boosted by a US$4.7 million one-off gain, ra", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-pdex/pro-dex/news/pro-dex-pdex-one-off-gain-clouds-68-trailing-earnings-growth", "source_name": "Simply Wall St", "published_at": "2026-02-06T04:53:00", "published_display": "06 Feb 2026 04:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Midday Stock Roundup: Pro-Dex Rises 5.6%", "summary": "Pro-Dex Inc. saw its shares rise 5.6% to $41.30, with hedge funds owning a significant portion of the medical device maker. In contrast, Evolus Inc. experienced a 4.1% drop after two analyst firms lowered their price targets due to recent downgrades. The article also provides a r", "url": "https://www.ocbj.com/finance/stocks/midday-stock-roundup-pro-dex-rises-5-6/", "source_name": "Orange County Business Journal", "published_at": "2026-01-26T18:27:33", "published_display": "26 Jan 2026 18:27", "sentiment": "positive", "sentiment_pct": 74, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "With 37% ownership, Pro-Dex, Inc. (NASDAQ:PDEX) has piqued the interest of hedge funds investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE1HSjFSTjhPVlQtWUJIdXdIa1RjTmRYbW1QYkVSWlVJN1V0T0tOdnI4N2Zhd25SU2hRUzlZOTg4dzBOOHBSeUkzSVZPUjB2cF9aaHZrOE1rT0VRZ0FZN0tXZGdYcllvOWxKcFVvaC12NzdCR1dDc0tKSU13?oc=5", "source_name": "Market source", "published_at": "2026-01-25T08:00:00+00:00", "published_display": "25 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pro-Dex: A Niche Surgical Tools Microcap Trading At A Discount (NASDAQ:PDEX)", "summary": "Pro-Dex (PDEX) manufactures powered surgical instruments and industrial air motors, serving niche markets in orthopedics, CMF, and thoracic procedures. Despite currently having a high concentration of revenue from a single customer (78% of sales), the company is considered underv", "url": "https://seekingalpha.com/article/4860659-pro-dex-a-niche-surgical-tools-microcap-trading-at-a-discount", "source_name": "Seeking Alpha", "published_at": "2026-01-18T00:57:42", "published_display": "18 Jan 2026 00:57", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Think Pro-Dex (NASDAQ:PDEX) Can Manage Its Debt With Ease", "summary": "Pro-Dex, Inc. (NASDAQ:PDEX) appears to manage its debt effectively, holding US$13.2m in debt against US$10.6m in cash, resulting in a net debt of US$2.69m. The company's strong balance sheet is further supported by US$6.11m more liquid assets than total liabilities. While its con", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-pdex/pro-dex/news/we-think-pro-dex-nasdaqpdex-can-manage-its-debt-with-ease", "source_name": "Simply Wall Street", "published_at": "2026-01-14T08:27:43", "published_display": "14 Jan 2026 08:27", "sentiment": "positive", "sentiment_pct": 70, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "D.A. Davidson & CO. Increases Holdings in Pro-Dex, Inc. $PDEX", "summary": "D.A. Davidson & CO. significantly increased its stake in Pro-Dex, Inc. (NASDAQ:PDEX) by 152.3% in the third quarter, now owning 26,073 shares worth $883,000. Other institutional investors also adjusted their holdings in the medical instruments supplier. Analysts have a \"Moderate ", "url": "https://www.defenseworld.net/2026/01/12/d-a-davidson-co-increases-holdings-in-pro-dex-inc-pdex.html", "source_name": "Defense World", "published_at": "2026-01-12T09:27:08", "published_display": "12 Jan 2026 09:27", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pro-Dex Valuation Is Attractive Despite Customer Risk (NASDAQ:PDEX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPMk1BazNrSWlUbjRqTExZM2JHMmMzczNwUTk5cHlRZHBGSlVzY184bXFEbW9IV205QTVmZEdORS1WMXp0R3FVVzBSX1hmck5GQ1pHNU1rT1RZNmFicjZMdk9TVXdaNTVjNkhDYTlvUHlTZHpOVm5VejFael9ocTI2R0FzSzEtTk8zLXZCT2ZkS1YyTXY2eHlpcWRB?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-01-08T08:00:00+00:00", "published_display": "08 Jan 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 71, "total_relevant": 25, "sentiment_summary": {"positive": 14, "negative": 4, "neutral": 7, "score": 58, "total": 25, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 77, "events": [{"event": "general", "label": "Market update", "weight": 7.3, "count": 12}, {"event": "earnings", "label": "Earnings", "weight": 5.3, "count": 9}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.55, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}], "positive_events": 14, "negative_events": 4}, "market_context": {"has_market_context": true, "latest_close": 62.89, "latest_week": "2026-07-10", "one_week_move": 2.5, "four_week_move": 1.1, "twelve_week_move": 17.8, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.256764, "market_dynamics_buy_signal": false, "relative_strength": 20.36128, "fair_value_gap": 84.1, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 50.9646, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.5% over one week, +1.1% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 67, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 3}, {"label": "Seeking Alpha", "count": 3}, {"label": "MarketBeat", "count": 3}, {"label": "Investing.com UK", "count": 2}, {"label": "Finviz", "count": 2}, {"label": "B\u00f6l\u00fcm Sonu Canavar\u0131", "count": 1}, {"label": "Stock Traders Daily", "count": 1}, {"label": "MEXC", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 25}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 12}, {"label": "Earnings", "count": 9}, {"label": "Macro sensitivity", "count": 1}, {"label": "Deals and strategy", "count": 1}, {"label": "Analyst action", "count": 1}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "58/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "77/100 classification confidence."}, {"label": "Company focus", "value": "25", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+2.5% over one week, +1.1% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Pro Dex director Domingo sells $47,145 of company stock By Investing.com"}], "updated_at": "2026-07-16T05:43:19.048715+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}